Nasal cytokines as mediators of illness during the common cold

Current Allergy and Asthma Reports

Volumn 5, Issue 3, 2005, Pages 173-181

  Doyle, William J ^a   Skoner, David P ^a   Gentile, Deborah ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; BRADYKININ; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE C4; LEUKOTRIENE DERIVATIVE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLACEBO; PROSTAGLANDIN; RANTES; RIMANTADINE; TUMOR NECROSIS FACTOR ALPHA; ZANAMIVIR;

ABSENTEEISM; ACUTE DISEASE; ADENOVIRUS; ALLERGIC REACTION; ANALYTIC METHOD; ANTIVIRAL ACTIVITY; ARACHIDONIC ACID METABOLISM; BACTERIAL INFECTION; BLOOD BRAIN BARRIER; CELL COMPARTMENTALIZATION; CELL POPULATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COMMON COLD; CORONAVIRUS; CORRELATION ANALYSIS; COXSACKIE VIRUS; CYTOKINE RELEASE; DISEASE CLASSIFICATION; DOWN REGULATION; DRUG EFFICACY; DRUG METABOLISM; DRUG TARGETING; EFFECTOR CELL; EPITHELIUM CELL; FOLLOW UP; HISTAMINE RELEASE; HOST CELL; HUMAN; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; LEUKOCYTE; METABOLIC RATE; NASAL BIOPSY; NEUTROPHIL; NOSE CONGESTION; NOSE MUCUS; PATHOGENESIS; PATHOPHYSIOLOGY; PILOT STUDY; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOPHARYNGITIS; RHINORRHEA; RHINOVIRUS; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; SNEEZING; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS SHEDDING;

EID: 20044366023     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0034-8     Document Type: Review

References (71)

1. Eggleston PA, Hendley JO, Gwaltney JM Jr.: Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection. Acta Otolaryngol Suppl 1984, 413:25-35.
2. Naclerio RM, Proud D, Kagey-Sobotka A, et al.: Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatr Infect Dis J 1988, 7:218-222.
3. Naclerio RM, Proud D, Lichtenstein LM, et al.: Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988, 157:133-142.
4. Demoly P, Crampette L, Mondain M, et al.: Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol 1994, 94:95-108.
5. McCormick DP, Saeed K, Uchida T, et al.: Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol 2003, 67:221-230.
6. Birch L, Elbrond O: Presence of interferon in the middle ear during secretory otitis media. Acta Otolaryngol 1987, 104:468-471.
7. Yellon RF, Doyle WJ, Whiteside TL: Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg 1995, 121:865-869.
8. Repka-Ramirez S, Naranch K, Park YJ, et al.: Cytokines in nasal lavage fluids from acute sinusitis, allergic rhinitis, and chronic fatigue syndrome subjects. Allergy Asthma Proc 2002, 23:185-190.
9. Hayden FG, Fritz R, Lobo MC, et al.: Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest 1998, 101:643-649.
10. McCormick DP, John SD, Swischuk LE, Uchida T: A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996, 35:457-460.
11. Gwaltney JM Jr, Winther B, Patrie JT, Hendley JO: Combined antiviral-antimediator treatment for the common cold. J Infect Dis 2002, 186:147-154.
12. Hayden FG: Update on influenza and rhinovirus infections. Adv Exp Med Biol 1999, 458:55-67.
13. Heikkinen T, Jarvinen A: The common cold. Lancet 2003, 361:51-59.
14. Bertino JS: Cost burden of viral respiratory infections: issues for formulary decision makers. Am J Med 2002, 112 (Suppl 6A):42S-49S.
15. Bramley TJ, Lerner D, Sames M: Productivity losses related to the common cold. J Occup Environ Med 2002, 44:822-829.
16. Brouwer WB, van Exel NJ, Koopmanschap MA, Rutten FF: Productivity costs before and after absence from work: as important as common? Health Policy 2002, 61:173-187.
17. Doyle WJ, McBride TP, Skoner DP, et al.: A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. Pediatr Infect Dis J 1988, 7:229-238.
18. Doyle WJ, Skoner DP, Alper CM, et al.: Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. J Infect Dis 1998, 177:1260-1265.
19. Doyle WJ, Alper CM, Buchanan CA, et al.: Illness and otological changes during upper respiratory virus infection. Laryngoscope 1999, 109(2 Pt 1):324-328.
20. Hagglund H: Allergies or colds? J Okla Dent Assoc 1984, 75:30, 31, 34.
21. Tyrrell DA, Cohen S, Schlarb JE: Signs and symptoms in common colds. Epidemiol Infect 1993, 111:143-156.
22. Schaffer J: The metaphysics of causation. In The Stanford Encyclopedia of Philosophy. Edited by Zalta EN. http://plato.stanford.edu/archives/spr2003/entries/causation-metaphysics/ (Spring2003)
23. Doyle WJ, Boehm S, Skoner DP: Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990, 86(6 Pt 1):924-935.
24. Skoner DP, Doyle WJ, Boehm S, Fireman P: Effect of terfenadine on nasal, eustachian tube, and pulmonary function after provocative intranasal histamine challenge. Ann Allergy 1991, 67:619-624.
25. Bose S, Banerjee AK: Innate immune response against nonsegmented negative strand RNA viruses. J Interferon Cytokine Res 2003, 23:401-412.
26. Bender BS, Small PA Jr: Influenza: pathogenesis and host defense. Semin Respir Infect 1992, 7:38-45.
27. Igarashi Y, Skoner DP, Doyle WJ, et al.: Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993, 92:722-731.
28. Doyle WJ, Skoner DP, White M, et al.: Pattern of nasal secretions during experimental influenza virus infection. Rhinology 1996, 34:2-8.
29. Proud D, Naclerio RM, Gwaltney JM, Hendley JO: Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990, 161:120-123.
30. Proud D, Reynolds CJ, Lacapra S, et al.: Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988, 137:613-616.
31. Skoner DP, Gentile DA, Fireman P, et al.: Urinary histamine metabolite elevations during experimental influenza infection. Ann Allergy Asthma Immunol 2001, 87:303-306.
32. Gentile DA, Fireman P, Skoner DP: Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 2003, 91:270-274.
33. Higgins PG, Barrow GI, Tyrrell DA: A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers. Antiviral Res 1990, 14:339-344.
34. Gustafson LM, Proud D, Hendley JO, et al.: Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996, 97:1009-1014.
35. Sperber SJ, Sorrentino JV, Riker DK, Hayden FG: Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull N Y Acad Med 1989, 65:145-160.
36. Sperber SJ, Hendley JO, Hayden FG, et al.: Effects of naproxen on experimental rhinovirus colds: a randomized, double-blind, controlled trial. Ann Intern Med 1992, 117:37-41.
37. Gwaltney JM Jr: Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis 1992, 166:776-782.
38. Turner RB, Sperber SJ, Sorrentino JV, et al.: Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold. Clin Infect Dis 1997, 25:824-830.
39. Muether PS, Gwaltney JM Jr: Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold. Clin Infect Dis 2001, 33:1483-1488.
40. Gwaltney JM Jr, Buier RM, Rogers JL: The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold. Antiviral Res 1996, 29:287-295.
41. Borish L, Rosenwasser LJ: Update on cytokines. J Allergy Clin Immunol 1996, 97:719-733; quiz 734.
42. Yoon HJ, Zhu Z, Gwaltney JM Jr, Elias A: Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. J Immunol 1999, 162:7461-7469.
43. Zhu Z, Tang W, Ray A, et al.: Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 1996, 97:421-430.
44. Zhu Z, Tang W, Gwaltney JM Jr, et al.: Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol 1997, 273(4 Pt 1):L814-L824.
45. Gentile DA, Yokitis J, Angelini BL, et al.: Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients. Ann Allergy Asthma Immunol 2001, 86:531-536.
46. Gentile DA, Doyle WJ, Belenky S, et al.: Nasal and oral nitric oxide levels during experimental respiratory syncytial virus infection of adults. Acta Otolaryngol 2002, 122:61-66.
47. Gern JE, Martin MS, Anklam KA, et al.: Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol 2002, 13:386-393.
48. Noah TL, Henderson FW, Henry MM, et al.: Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995, 171:584-592.
49. Roseler S, Holtappels G, Wagenmann M, Bachert C: Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 1995, 252(Suppl 1):S61-S63.
50. Kaiser L, Fritz RS, Straus SE, et al.: Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 2001, 64:262-268.
51. Proud D, Gwaltney JM Jr, Hendley JO, et al.: Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994, 169:1007-1013.
52. Turner RB, Weingand KW, Yeh CH, Leedy DW: Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 1998, 26:840-846.
53. Yuta A, Doyle WJ, Gaumond E, et al.: Rhinovirus infection induces mucus hypersecretion. Am J Physiol 1998, 274(6 Pt 1):L1017-L1023.
54. Gem JE, Vrtis R, Grindle KA, et al.: Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000, 162:2226-2231.
55. Gentile DA, Villalobos E, Angelini B, Skoner D: Cytokine levels during symptomatic viral upper respiratory tract infection. Ann Allergy Asthma Immunol 2003, 91:362-367.
56. Linden M, Greiff L, Andersson M, et al.: Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 1995, 25:166-172.
57. Noah TL, Becker S: Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000, 97:43-49.
58. Gentile D, Doyle W, Whiteside T, et al.: Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol 1998, 5:604-608.
59. Cohen S, Doyle WJ, Skoner DP: Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med 1999, 61:175-180.
60. Skoner DP, Gentile DA, Patel A, Doyle WJ: Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis 1999, 180:10-14.
61. Fritz RS, Hayden FG, Calfee DP, et al.: Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 1999, 180:586-593.
62. Bonville CA, Rosenberg HF, Domachowske JB: Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol 1999, 10:39-44.
63. Sheeran P, Jafri H, Carubelli C, et al.: Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999, 18:115-122.
64. Hornsleth A, Klug B, Nir M, et al.: Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr Infect Dis J 1998, 17:1114-1121.
65. Hornsleth A, Loland L, Larsen LB: Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol 2001, 21:163-170.
66. Oh JW, Lee HB, Park IK, Kany JO: Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr Allergy Immunol 2002, 13:350-356.
67. Garofalo RP, Hintz KH, Hill V, et al.: Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol 2004, 73:289-294.
68. Gentile DA, Doyle WJ, Zeevi A, et al.: Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol 2003, 64:338-344.
69. Gentile DA, Doyle WJ, Zeevi A, et al.: Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults. Hum Immunol 2003, 64:93-98.
70. Skoner DP, Doyle WJ, Seroky J, Fireman P, et al.: Lower airway responses to influenza A virus in healthy allergic and nonallergic subjects. Am J Respir Crit Care Med 1996, 154(3 Pt 1):661-664.
71. Gentile DA, Doyle WJ, Fireman P, Skoner DP: Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects. Ann Allergy Asthma Immunol 2001, 87:496-500.